Literature DB >> 27133696

Imaging findings, diagnosis, and clinical outcomes in patients with mycotic aneurysms: single center experience.

Amy R Deipolyi1, Alexander Bailin2, Ali Khademhosseini3, Rahmi Oklu4.   

Abstract

PURPOSE: To review the presentation, imaging, clinical management, and outcomes in patients with mycotic aneurysm (MA).
METHODS: Fifty-five cases in 49 patients (33 men, 16 women, average age: 66.2years) were identified.
RESULTS: Of 49 patients, only 20% presented with the classic clinical triad of fever, elevated white count, and pain. Computed tomography was the most utilized imaging modality; focal vascular outpouching was the most frequent imaging finding (76%). There was 17% mortality rate within 6months of diagnosis despite intervention.
CONCLUSIONS: Clinical presentation and blood cultures can be nonspecific, highlighting the importance of imaging diagnosis of MA to expedite treatment.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mycotic aneurysm; diagnosis; imaging; infection

Mesh:

Year:  2015        PMID: 27133696     DOI: 10.1016/j.clinimag.2015.12.002

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  3 in total

Review 1.  Inflammatory and infectious aortic diseases.

Authors:  Amy R Deipolyi; Christopher D Czaplicki; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

2.  Clinical and microbiological characteristics and challenges in diagnosing infected aneurysm: a retrospective observational study from a single center in Japan.

Authors:  Kohsuke Matsui; Kensuke Takahashi; Masato Tashiro; Takeshi Tanaka; Koichi Izumikawa; Takashi Miura; Kiyoyuki Eishi; Akitsugu Furumoto; Koya Ariyoshi
Journal:  BMC Infect Dis       Date:  2022-06-30       Impact factor: 3.667

3.  Massive hemobilia due to a ruptured mycotic hepatic artery aneurysm associated with streptococcal endocarditis: case report.

Authors:  Jia-Ying Zhu; Jia Huang; Wei Fan; Xia Lv; Yi-Pin Ren; Xiu-Lin Yang
Journal:  J Int Med Res       Date:  2019-11-10       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.